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ABSTRACT
Objectives: Headaches and facial pain have been
identified as the most prevalent form of pain among
patients with glioblastoma multiforme, the most
common malignant primary brain tumour. Despite this,
minimal research has been undertaken investigating the
direct and indirect impact these headaches have on
their quality of life. Therefore, in this study, we aimed
at gaining a personal insight into the importance and
impact that these headaches have on the quality of life
of patients with glioblastoma multiforme.
Design: Exploratory study using face-to-face
semistructured interviews. Interviews were audio-
recorded, transcribed verbatim and then qualitatively
analysed using thematic analysis.
Setting: Participants recruited from a tertiary referral
hospital in Birmingham, UK.
Participants: Purposive sampling of 14 registered
outpatients recently diagnosed with glioblastoma
multiforme.
Results: 3 themes were identified: (1) an underlying
attitude of determination and positivity; (2) impact of
headache unpredictability on social interaction; (3)
headaches found to act as a springboard onto
thoughts regarding their disease and future.
Conclusions: While the quality of life of patients with
glioblastoma multiforme is clearly multifactorial,
headaches do indeed play a part for some. However, it
is not the direct pain of the headache as one might
expect that impacts on the quality of life of these
patients, but the indirect effect of headaches through
limiting patients’ social lives and by serving as a
painful psychological reminder of having a life-
threatening illness. In clinical practice, using headache
diaries for these patients may help provide a more
comprehensive assessment and further aid
management plans. Alongside acting as an important
reminder of the potential secondary implications of this
disease, suggestions for future research include
quantitatively investigating whether headaches can act
as a prognostic indicator for quality of life within this
patient demographic and determining whether these
conclusions also hold true for a wider spectrum of
patients with brain tumour.
BACKGROUND
Glioblastoma multiforme (GBM) tumours
are histologically the second most frequently
reported primary brain and central nervous
system tumour (accounting for 16%) and the
most common form of malignancy within
this subset of neoplasms,1 with an annual
incidence in the USA and Europe of 3 per
Strengths and limitations of this study
▪ As far as the authors know this is the first
descriptive exploratory study that has investi-
gated the impact that headaches have on patients
with aggressive brain tumours and the subse-
quent coping mechanisms that patients develop
in response to this.
▪ The nature of the semistructured interviews and
iterative process of analysis allowed emerging
themes to be built on as the research progressed
and hence develop a deeper understanding of
the issues discussed.
▪ Family members present during the interviews
may have had the potential to affect the way in
which participants answered questions, espe-
cially when discussing such a personal and
emotive subject as quality of life. However,
overall it was seen as a benefit having them
present as in most cases they aided in partici-
pant memory recall.
▪ Participation in the study was completely volun-
tary; hence, all participants were willing to talk
about the impact of their symptoms on their
quality of life—potentially missing patients who
were eligible as far as the inclusion and exclu-
sion criteria were concerned, but unwilling to
discuss their quality of life and symptoms.
▪ All participants were newly diagnosed with a
glioblastoma multiforme tumour and therefore
the results may not be directly transferable to
patients with recurrent glioblastoma multiforme
who have had more time to process and live
with their condition.
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100 000 people.2 The median age of diagnosis of this
2:1 male predominant disease is 64 years and it is the
most aggressive form of the group of brain tumours
known as astrocytomas (themselves a form of glioma).3
GBM tumours are categorised as a grade IV astrocy-
toma, stipulated by the WHO system, which grades
astrocytomas from I to IV.4 Despite advances in treat-
ment technology over the past few years, in particularly
with regard to chemotherapy,5 due to the widely inﬁl-
trative nature and rapid growth of this tumour, asso-
ciated life expectancy is still low,3 with a median
survival of 15 months from diagnosis and a 2-year life
expectancy ranging from 8% to 26%.6 To improve
patient survival, standard treatment usually involves sur-
gical debulking and biopsy of the tumour, followed by
radiotherapy and chemotherapy.5 As a result of this
poor prognosis in GBM, matters of quality of life
(QoL) become of utmost importance to patients and
those around them.7
The term QoL encompasses multiple aspects of a
patient’s overall well-being, including physical, material,
social and emotional well-being.8 Over the past two
decades, as survivorship of GBM has gradually increased
and patients have survived longer to experience the
comorbidities of associated treatments,6 9 10 QoL has
become an ever more important factor in the manage-
ment of such patients. Recommendations have
been made for randomised trials to include QoL and
palliative care outcomes as end points,11 although
reliably measuring QoL in patients with high-grade
glioma has proven difﬁcult due to high rates of drop out
bias and loss of participants’ ability to complete complex
forms.12
A signiﬁcantly reduced overall QoL is seen in the
majority of newly diagnosed patients with high-grade
glioma, when compared with healthy controls.13 14
Descriptive research into the speciﬁc symptoms that
affect QoL in patients with glioma has primarily focused
on six manifestations: fatigue, sleep, pain, seizures,
mood disturbance and cognitive function.15 However,
despite headaches having been reported as the most
prevalent form of glioma-associated pain, experienced
by up to 52% of patients with GBM,16 most commonly as
dull tension-type headaches,17 18 and control of primary
central nervous system tumour headaches being noted
as crucial,19 no widely available or published research
has investigated the impact that these headaches
have on the QoL of patients with GBM. This may partly
be due to the multifaceted complexity of investigating
QoL and gaining patients’ perspectives within this
population.
Hence, with up to half of patients with GBM being
affected by headaches,16 if an association between head-
aches and QoL is identiﬁed, a deeper understanding of
this could lead to the implementation of appropriate
precautions or interventions, with the aim of improving
the management of headaches in patients with GBM
and subsequent QoL.
AIMS
1. To establish an insight into the importance of head-
aches to patients with GBM.
2. To investigate the impact of headaches on the
mindset of patients being treated for an aggressive
brain cancer.
METHODS
Design
This exploratory qualitative study employed face-to-face
semistructured interviews with patients being treated for
GBM at the Queen Elizabeth Hospital Birmingham
(QEHB)—all of which were interviewed between 5 and
21 weeks postradiotherapy. At the time of the interview,
participants were at various stages of their adjuvant
temozolomide chemotherapy cycle, with each partici-
pant only interviewed once. The purpose of selecting
this time period was to interview participants in a pos-
ition where they felt they had enough experience to talk
and reﬂect about their condition, symptoms and asso-
ciated QoL. Additionally, all participants were required
to be over the age of 18 at the time of being informed
of the study. Potential participants with a WHO
Performance Status >2 (not capable of self-care) were
excluded from the study due to the severity of their
illness. Owing to this study being the ﬁrst of its kind in
this speciﬁc area of research, use of questionnaires and
a quantitative approach was dismissed as it was felt this
may miss out on in-depth speciﬁc details regarding QoL.
When investigating the complexity of human behaviour,
a qualitative approach may more likely highlight these
due to the themes that emerge when participants are
allowed to discuss what is important to them.20 Such an
approach has been successful in similar research in
patients with other cancers and congenital heart
disease.21 22 Additionally, due to the limited time frame
and resources, the feasibility of recruiting a sample size
capable of statistical signiﬁcance from questionnaire
data would have been low.
Sample size
Of the 21 eligible participants, identiﬁed from
neuro-oncology clinic lists and informed of the study
using purposive sampling, 14 were subsequently inter-
viewed within the Cancer Centre Department of the
QEHB. Of the seven who were not interviewed, four
were because of late hospital appointment changes, with
only three actively declining to take part.
Data collection
Over a 5-month period (February to April, July and
September 2015) potential participants were identiﬁed
and informed of the study by a MacMillan Clinical
Nurse Specialist in their existing care team. This was
carried out either face-to-face or by telephone, using a
participant information sheet to explain the purpose of
the research, with interviews scheduled to coincide with
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their next outpatient appointment at the QEHB. The
interviews, each lasting 15–40 min, were undertaken by a
senior medical student (SRB), as part of a qualitative
focused intercalated research degree, following a pre-
written interview topic guide (see online supplementary
ﬁle 1). This topic guide was designed by the research
team (SRB and AL) to explore both headache and non-
headache participants’ views regarding the changes in
their life and symptoms experienced in the build up to
and since their diagnosis of GBM. This speciﬁcally
focused on QoL and the impact that headaches or the
potential for headaches and what they had now come to
represent had on this. The reasoning for asking add-
itional questions, not just related to headaches, was so
that the interviewer could immerse themselves and
grasp as much as possible regarding the personal chal-
lenges that these patients now face—in turn allowing for
a more comprehensive understanding and analysis of
the impact and role that headaches play within this.
Owing to the small-scale nature of the study and time
restrictions, the topic guide was not pilot tested with par-
ticipants; however, the semistructured nature of these
interviews and iterative process of analysis allowed a con-
tinuous adaption of the interview guide throughout the
study, so as to build on emerging themes. As the study
progressed, no questions were added or removed from
the interview guide, but greater emphasis was placed on
the thoughts and feelings that participants associated
with headaches. No ﬁeld notes were made during the
interviews; however, each interview was transcribed as
soon as possible so as to retain non-verbal information
that the interviewer identiﬁed during the interview.
Data analysis
Data were analysed following Braun and Clarke’s 6 Step
Thematic Analysis, allowing identiﬁcation and analysis of
patterns and themes.23 The interviews, audio-recorded
digitally, were transcribed verbatim (including notes on
participant body language), with transcripts read and
re-read to ensure familiarity, before deriving codes.
Once interviews were coded, they were then collated to
generate themes and extract important issues, viewpoints
and dynamics, which led to a subsequent active data
search for disconﬁrming evidence.21 Analysis of derived
codes and theme recognition was carried out independ-
ently by the interviewer (SRB), a lecturer in qualitative
methods (AL) and an additional senior medical student
(SRM), to identify and understand potential multiple
interpretations of the data and reduce the likelihood of
producing results which were partial or biased.24 This
theme identiﬁcation began before data collection was
complete in order to explore initial ﬁndings in greater
depth. All research activities were recorded in detail to
allow methodological critical appraisal and increase
trustworthiness, a concept used to describe reliability in
qualitative research.25
However, due to the limited time frame, further validity
checking using participant veriﬁcation was not feasible.
Interviews were selected over focus groups due to the
highly sensitive nature of discussing QoL within this
population, where participants may have felt reluctant to
divulge such personal information in front of strangers.
However, a family member was allowed to contribute to
the interview, if requested so by the participant.
Research ethics
All patients who took part in this study participated vol-
untarily. Written informed consent was taken from all
participants prior to starting each scheduled interview,
which were all undertaken within a quiet conﬁdential
setting in the Cancer Centre, QEHB. Participants were
also informed that they could stop the interview at any
point for any reason. All conﬁdential participant infor-
mation was stored on encrypted memory sticks, access-
ible only to the researchers.
RESULTS
Of the 14 participants (median age=47.5 (IQR 38–63)
years; 8 male) interviewed, 6 reported as experiencing
headaches within the last month, 1 reported a unilateral
facial pain and 1 other with lightheadedness, but no
headaches (table 1). The remaining six patients
reported as having neither headaches nor facial pain
nor lightheadedness. All participants reported varying
levels of tiredness and fatigue. Additionally, all partici-
pants requested to have a family member or carer
present during the interviews.
Grouping and interlinking of codes, derived from all
of the transcribed interviews, yielded three themes,
however only the ﬁrst two of these, ‘underlying deter-
mination and positivity’ and ‘headache of social situa-
tions’, were initially apparent. These themes primarily
describe the thoughts, feelings and emotions conveyed
by the participants, regarding their approach to the
challenges that day-to-day life now presents and the role
of headaches within this. Only after full data immersion
and code collaboration was the third theme, ‘psycho-
logical springboard of headaches’, developed. This ﬁnal
theme aims to provide an insight into the potential
implications that headaches, and what they have now
come to represent, may have on self-contemplation in
this population regarding their condition and future. Of
these themes, ‘underlying determination and positivity’
was developed from all participants (both headache and
non-headache), with the remaining two themes devel-
oped only from the six participants who developed
headaches and the two participants who reported facial
pain and lightheadedness.
Underlying determination and positivity
A consistent theme among almost all participants was a
resounding determination to ‘get on with life’ and not
to be bound by the symptomatic implications of their
condition, referred to by several as ‘the nature of the
beast’:
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I try not to think about it, which may not be the healthi-
est psychological way to go about it. However, it just
means I can get on throughout the day, getting on with
things that I like to do and want to do. (P2)
Acceptance of the situation, alongside the want and
almost need to block it out in order to carry on with as
normal a life as possible, was a commonly reported trait.
Potential reasoning to partially explain this behaviour
can be drawn from the frequently reported frustration
that came with participant’s self-recognition of dwelling
on their illness:
obviously I think about the future, because I know it’s
not curable, it’s a controllable cancer…it’s a bit frustrat-
ing if you think about it too much, but then you’ve got to
be thankful for what you’ve still got. (P5)
While this theme is not directly related to headaches,
the principle of leading as normal life as possible was
the fundamental aspect of most of the participants’
approach to their brain tumour, expressed by 12 of the
14 interviewed. With this in mind, this then helps con-
textualise the next two themes, discussing ways in which
headaches were found to disrupt normality.
Headache of social situations
While not all participants reported as having headaches,
three of the six who did noted the subsequent impact
on their social lives:
I do kind of think if I’m on good form I’ll be alright and
it’ll be fun, but if I don’t feel good it won’t be fun…I
don’t really know what to say or how to join in. (P4)
For this participant, the key issue with group inter-
action was that her symptoms of headaches and fatigue
were experienced unpredictably and when they were
experienced ‘you kind of feel like you’re a bit discon-
nected, like you can’t think properly and it’s hurting’.
While admitting that the headaches she experienced
were not ‘debilitating’, they or the concern of them had
prevented her from so far socialising with groups of
friends. Similar reservations regarding socialising in a
group were also reported by other participants:
I’m very happy to see my friends one-to-one, but the
thought of seeing people in a group, I don’t know if I
feel that’s a bit more intimidating than I would have
done beforehand. (P2)
While feeling comfortable socialising one-to-one with
people, this participant expressed worry about interact-
ing in a group in case they started having headaches—
their concern stemming from the fact that they would
not then want the rest of the group to start worrying
about them.
Psychological springboard of headaches
The ﬁnal theme that emerged was an awareness, and in
some cases fear, of the negative connotations that head-
aches had now become associated with. When feeling
‘tired and headachey’, several participants reported it
made them think ‘oh, what is going on in my head’ and
acted as a springboard onto subsequent negative
thoughts regarding their condition and future:
You start to think “oh is there something else going on
upstairs”. (P11)
Here, this participant talked about the consequent
effect on thought process and rationale that their light-
headedness and frequent twinges in their forehead now
held for them. While they expressed their determination
to maintain a positive outlook, these symptoms were
often an untimely and certainly unwanted reminder of
their cancer.
As identiﬁed in the ﬁrst theme, a positive mentality
was the overwhelming attitude conveyed by the
Table 1 Participant information
Participant
number Gender
Number of weeks interviewed
postradiotherapy
Headaches experienced within the last
month
1 Male 12 Yes
2 Female 8 Yes
3 Male 8 Yes
4 Female 5 Yes
5 Female 13 No
6 Female 13 Yes
7 Female 12 No
8 Male 5 No (but facial sensitivity/pain)
9 Male 5 Yes
10 Male 20 No
11 Male 15 No (but lightheadedness)
12 Male 8 No
13 Male 18 No
14 Female 17 No
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participants. To maximise this positive outlook and avoid
these psychological reminders of their condition, partici-
pants voiced that they had adapted their lives to minim-
ise the chance of headaches:
The only thing that I don’t do is drink alcohol anymore,
and that’s not because I’m not allowed to…It’s probably
the fact that I don’t want to have a glass of wine if that’s
going to give me a headache. (P6)
With this participant, if headaches were to become
more regular, she admitted she would assume the worst
and think ‘oh, it’s growing and growing and growing and
taking over my head’, even if the headache aetiology
could clearly be associated with some far more benign
behavioural activity (such as caffeine or alcohol). Similar
participant reﬂection revealed an insight into how head-
aches may not only act as a psychological springboard but
also as a further symptomatic springboard:
They may possibly have been part of the reason that I
wasn’t sleeping properly, because, they were part of the
reason I wasn’t feeling great. (P3)
While this participant was conﬁdent that the sporadic
headaches he had been experiencing were not the
cause of his waking at night, they may have contributed
to him struggling to fall back asleep, leading to not only
contemplation of his condition and future at night, but
also to day time tiredness, subsequently limiting activities
of daily living. This is a crucial point, as the double-edge
of cancer is that it not only limits life expectancy, but
also limits the amount that patients are capable of doing
in this remaining time. In terminal cancer, this is even
more so relevant, where treatment often shifts towards
prioritising QoL.
DISCUSSION
During analysis, three themes emerged: ‘underlying
determination and positivity’, ‘headache of social situa-
tions’ and ‘psychological springboard of headaches’.
While most participants agreed that headaches them-
selves did not cause great direct physical pain, and
would only start to worry about headache pain more if
they were ‘more prolonged’ or ‘severe’, this may have
been affected by the symptoms experienced in the run
up to diagnosis, of which several had severe headaches.
Owing to previous experience of severe headaches, diag-
nosis of GBM and adequate time to reﬂect on their situ-
ation, the emotional and psychological impact of
headaches and coming to terms with their condition was
more often (n=5 of 6 headache participants) found to
be greater than their physical sequela.
Furthermore, a seemingly key aspect within this popu-
lation, to maintaining QoL and partaking in normal
activities of daily living, was to focus on the positive and
not the negative aspects of their lives—with participants
reporting both actively trying not to think negatively,
and passively by immersing themselves in hobbies, socia-
lising, travelling or even returning to work. This partici-
pant behaviour of seeking normality and attempts to
distance themselves from the taboo of cancer has been
previously identiﬁed in similar qualitative interviews
focusing on the QoL of patients with anal cancer.21
However, when symptoms were experienced and
impacted on day-to-day life, it became harder for partici-
pants to forget about their condition. Within this, some
symptoms were seen to be associated with fewer negative
connotations, for example, tiredness and fatigue, to
which participants reported incorporating increased rest
and daytime sleep into their daily routine, but did not
tend to think too much into them. However, headaches
had more scope to play on the mind (reported by four
of the six participants with headaches). This may be due
to the more direct and potentially easier link to psycho-
logically make between headaches and the knowledge of
having a brain tumour, than fatigue and a brain tumour.
Hence, the presence of headaches may make the ability
to forget about the situation that these patients are
facing harder, subsequently indirectly impacting on
QoL. Additionally, of the eight participants who
reported not having headaches, ﬁve voiced that if they
did start experiencing headaches, they would likely
jump to conclusions and panic about the aetiology.
Recommendations
Potential interventions could include transferring life-
style management strategies from the standard treatment
of tension-type headaches, such as keeping a headache
diary to identify triggers or exacerbating factors as well
as aiming to relieve patients with GBM of the worry sur-
rounding the aetiology of their headaches;26 however, a
downside of this could be even further contemplation of
their condition. While it was felt that saturation was
reached in this study (with themes becoming repetitive
by the latter stages and no new themes emerging), if
similar qualitative research was to be conducted, asses-
sing whether the results of this study also holds true for
a range of other malignant or even benign brain
tumours, a larger sample size would be recommended if
multiple disease pathologies were to be allowed within
the inclusion criteria. It could also be investigated
whether headaches can be used to predict QoL within
this population, by undertaking a prospective longitu-
dinal study aiming to identify whether the presence of
headaches immediately postradiotherapy (when QoL is
considered to be at its worst) can act as a prognostic
indicator for QoL during the adjuvant phase of treat-
ment. Validated questionnaires, such as the European
Organisation for Research and Treatment of Cancer
Quality of Life Questionnaire C30 and BN20, could be
provided to patients postradiotherapy and then again
several months later. Here, an upward trend of QoL
would be expected, with this proposed study aiming to
identify whether the presence of headaches affects the
trajectory of this upward curve.
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Limitations
Limitations include a small sample size (however, this is
normal for qualitative research) and family present
during the interview having the potential to affect parti-
cipants’ answers. In addition, participation in the study
was completely voluntary; hence, all participants were
willing to talk about the impact of their symptoms on
their QoL (potentially missing patients who were eligible
as far as the inclusion criteria, but unwilling to discuss
their QoL and symptoms). Additionally, participants
interviewed within this study were all undergoing treat-
ment for a newly diagnosed GBM tumour and hence
the results may not be transferable to patients with
recurrent GBM. Participants were either undergoing or
had recently undertaken adjuvant temozolomide in the
chemotherapy phase of their treatment; however, the
exact phase of the chemotherapeutic cycle that they
were in at the time of the interview was not recorded
and neither was their current medication regime.
Initially, inclusion criteria stipulated that patients be
5–9 weeks postradiotherapy at the time of interview;
however, due to the limited time period of the study, it
was realised this would not be feasible to recruit enough
participants and hence was expanded to 5–21 weeks. A
further difﬁculty encountered was classifying exactly who
had headaches, with one participant reporting a unilat-
eral facial pain and another with pronounced lighthead-
edness; however, both were quite adamant they were not
experiencing headaches and as such were recorded that
way. Memory recall of headaches experienced was not
seen as a limitation, as when a participant was unsure of
the timings of their headaches, they were offered help
by their family member in attendance.
Owing to the multifaceted complexity that QoL presents
in patients with brain tumour, research speciﬁcally focusing
on the burden of just one symptom that plays a role in this
is challenging. While headaches are not the most prevalent
symptom experienced by this population, they are indeed
experienced by a signiﬁcant proportion. Through identify-
ing themes consistent among patients with GBM with head-
aches, we seek to gain a deeper understanding of the
day-to-day challenges that this cohort faces, with the aim of
further facilitating patient management.
Despite these limitations, the principles raised in this
study may possibly be applicable, at least to varying
extents, to a larger population of not just patients with
GBM, but potentially also other patients with high-grade
malignant and terminal brain cancer or even patients
with benign brain tumours experiencing headaches.
CONCLUSION
The aim of this qualitative study was to investigate and
address the impact, importance and interaction of head-
aches experienced by patients with GBM, on their QoL.
While not all participants reported as experiencing head-
aches, those that did considered the physical pain of their
headaches not to be severe or prolonged enough to
directly impact on QoL. However, during interview ana-
lysis, three participant themes emerged regarding the
strive to not be bound by the symptomatic implications of
their condition, the indirect impact of headaches on
socialisation and headaches acting as a painful psycho-
logical reminder in certain participants of the signiﬁcance
of the threat to their autonomy and survival. These emer-
gent themes should act as important reminders to clini-
cians of the secondary impacts and underlying mindset of
patients having been diagnosed or undergoing treatment
for GBM, in particularly if they have been experiencing
headaches. Implications for clinical practice include the
potential for providing patients with headache diaries to
allow a more comprehensive holistic assessment of patients
with GBM experiencing headaches. Directions for further
research include investigating whether headaches can be
of clinical value by being used as a prognostic indicator for
QoL and exploring if the themes raised in this study also
bear relevance to subsets of patients with a wider spectrum
of brain tumours.
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